Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD
Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.
Stay updated with breaking news from Ageing Res. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 16, 2023--
The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psychopharmacologic Drugs Advisory C...
Study successfully achieved both primary and secondary objectives ANAVEX®2-73 treatment resulted in improvements of all efficacy endpoints over 48 Weeks Anavex plans to proceed to... | March 30, 2023
Omega-3 fats, whey and exercise are just some meaningful ways to fight sarcopenia, or age-related muscle loss, before ...